Journal of Peking University(Health Sciences) ›› 2020, Vol. 52 ›› Issue (1): 163-168. doi: 10.19723/j.issn.1671-167X.2020.01.026

Previous Articles     Next Articles

Musculoskeletal ultrasound findings of symptomatic joints in patients with systemic lupus erythematosus

Yan GENG,Bo-rui LI,Zhuo-li ZHANG()   

  1. Department of Rheumatology, Peking University First Hospital, Beijing 100034, China
  • Received:2018-07-09 Online:2020-02-18 Published:2020-02-20
  • Contact: Zhuo-li ZHANG E-mail:zhuoli.zhang@126.com
  • Supported by:
    Supported by the Beijing Natural Science Foundation(7184251);the Capital Foundation for Clinical Characteristics and Application Research(Z151100004015129)

RICH HTML

  

Abstract:

Objective:To investigate the types and distribution of musculoskeletal ultrasonographic changes of the symptomatic joints, their correlations with clinical manifestations in systemic lupus erythematosus (SLE) patients, as well as the differences of ultrasonographic changes from Rhupus syndrome [SLE overlapping with rheumatoid arthritis (RA)] patients. Methods: In the study, 114 SLE patients who complained of arthralgia or arthritis from May 2014 to August 2017 and 15 Rhupus syndrome patients were recruited for ultrasound evaluation. Ultrasound scans of the symptomatic joint areas were completed. The correlation between ultrasonographic changes and clinical characteristics was analyzed. Additionally, ultrasound changes of bilateral wrists and hands of the SLE patients were compared with those of the Rhupus syndrome patients. Results: In a total of the 114 SLE patients with 1 866 joints scanned, synovial hyperplasia, tenosynovitis, erosion, and osteophytes were all observed. Synovial hyperplasia was more often observed in wrists in 33.3% (23/69) patients, knees in 28.6% (12/42) patients, and ankles in 25.0% (7/28) patients. Tenosynovitis and erosion were most commonly found in shoulders in 35.0% (7/20) and 65.0% (13/20) patients. Osteophytes were more common in proximal interphalangeal (PIP) joints, elbows and knees. Among 69 patients with 22 joints (bilateral wrists and hands) scanned, 57 (82.6%) of them had ultrasonographic changes. Synovial hyperplasia was observed in 36.2% of the patients and erosion in 14.5% of the patients. The agreement between synovial hyperplasia and swollen joints in PIP was fair (κ=0.633, P<0.01), however poor in wrists between synovial hyperplasia and swollen/tender joints (κ=0.089, P=0.584). 18.4% patients with synovial hyperplasia had no tenderness or swollen clinically, while 15.8% patients with tenderness or swollen had no synovial hyperplasia on ultrasound. No correlation was found between ultrasonographic changes with the SLE disease activity index. Both synovial hyperplasia and erosion were more common in the Rhupus syndrome patients (73.3% vs. 36.2%, P=0.08; 66.7% vs. 14.5%, P=0.03) with significantly higher grey scale scores (7.4±6.4 vs. 1.6±4.1, P=0.04) than in the SLE patients. Conclusion: Variety of changes could be observed by ultrasound in different joint areas of SLE patients. The ultrasonographic changes and clinical manifestations did not always correspond to each other. Synovial hyperplasia and erosion was more common in Rhupus syndrome patients.

Key words: Systemic lupus erythematosus, Joint diseases, Musculoskeletal ultrasound

CLC Number: 

  • R593.2

Table 1

Demographic and clinical features in SLE patients with symptomatic hand and wrist joints (n=69)"

Demographic and clinical features Data
Female, n (%) 62 (88.5)
Age/years, x?±s 43.7±15.0
Disease duration/years, median (min, max) 6.0 (0.1, 40.0)
Joint involvement, n (%) 55 (79.7)
Skin involvement, n (%) 33 (47.8)
Raynaud’s phenomenon, n (%) 5 (7.2)
Lupus nephritis, n (%) 34 (49.2)
Neuropsychiatric lupus, n (%) 2 (2.9)
Hematologic involvement, n (%) 29 (42.0)
Hemolytic anemia, n (%) 5 (7.2)
Leukopenia, n (%) 24 (34.7)
Thrombocytopenia, n (%) 10 (14.5)
Interstitial lung disease, n (%) 5 (7.2)
Serositis, n (%) 3 (4.3)
ANA positive, n (%) 69 (100.0)
Anti-dsDNA positive, n (%) 46 (66.7)
Anti-Sm positive, n (%) 12 (17.3)
Anti-nRNP positive, n (%) 30 (43.4)
Anti-SSA positive, n (%) 35 (50.7)
Anti-SSB positive, n (%) 7 (10.1)
Anti-rRNP positive, n (%) 16 (23.2)
Complement 3/(g/L), x?±s 0.64±0.29
Complement 4/(g/L), x?±s 0.12±0.07
IgG/(g/L), x?±s 18.7±7.7
Rheumatoid factor positive, n (%) 15 (21.7)
SLEDAI score, x?±s 10.0±6.2

Table 2

The agreement between physical examination and ultrasonographic synovial hyperplasia & synovitis in wrist"

Ultrasonographic Physical examination P κ
Synovial hyperplasia Tender joint 0.419 0.130
Synovial hyperplasia Swollen joint 0.746 -0.050
Synovial hyperplasia Tender joint and/or swollen joint 0.584 0.089
Synovitis Tender joint 0.133 0.224
Synovitis Swollen joint 0.593 0.084
Synovitis Tender joint and/or swollen joint 0.191 0.190

Table 3

The agreement between physical examination and ultrasonographic synovial hyperplasia in hand"

Ultrasonographic Physical examination P κ
Synovial hyperplasia Tender joint 0.019 0.327
Synovial hyperplasia Swollen joint <0.001 0.633
Synovial hyperplasia Tender joint and/or swollen joint 0.069 0.229

Table 4

Comparison of the clinical and ultrasonographic features between SLE patients and Rhupus syndrome patients"

Clinical and ultrasonographic features SLE group (n=69) Rhupus syndrome group (n=15) P
Female, n (%) 62 (88.5) 14 (93.3) 0.576
Age/years, x?±s 43.7±15.0 48.4±14.9 0.651
Disease duration/years, median (min, max) 6.0 (0.1, 40.0) 10.0 (1.0, 46.0) 0.061
Joint involvement, n (%) 55 (79.7) 15 (100.0) 0.064
Lupus nephritis, n (%) 34 (49.2) 8 (53.3) 0.776
Hematologic involvement, n (%) 29 (42.0) 12 (80.0) <0.001
Serositis, n (%) 3 (4.3) 7 (46.7) <0.001
ANA positive, n (%) 69 (100.0) 15 (100.0)
Anti-dsDNA positive, n (%) 46 (66.7) 12 (80.0) 0.311
Anti-Sm, n (%) 12 (17.3) 6 (40.0) 0.053
Anti-nRNP, n (%) 30 (43.4) 7 (46.6) 0.822
Anti-rRNP, n (%) 16 (23.2) 3 (20.0) 0.789
Anti-SSA, n (%) 35 (50.7) 7 (46.6) 0.776
SLEDAI, x?±s 10.0±6.2 10.0±5.3 0.834
Complement 3/(g/L), x?±s 0.64±0.29 0.56±0.35 0.476
IgG/(g/L), x?±s 18.7±7.7 23.0±8.1 0.727
RF, n (%) 15 (21.7) 10 (66.7) 0.060
Synovial hyperplasia (GS>0), n (%) 25 (36.2) 11 (73.3) 0.083
Synovitis (PD>0), n (%) 11 (18.9) 5 (33.3) 0.121
GS score, x?±s 1.6±4.1 7.4±6.4 0.040
PD score, x?±s 0.4±1.4 1.1±1.8 0.613
Bone erosion, n (%) 10 (14.5) 10 (66.7) <0.001
[1] Zoma A . Musculoskeletal involvement in systemic lupus erythematosus[J]. Lupus, 2004,13(11):851-853.
[2] Drenkard C, Bao G, Dennis G , et al. The burden of systemic lupus erythematosus on employment and work productivity: data from a large cohort in the southeastern United States[J]. Arthritis Care Res, 2014,66(6):878-887.
[3] Naredo E, Bonilla G, Gamero F , et al. Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography[J]. Ann Rheum Dis, 2005,64(3):375-381.
[4] Wakefield RJ, Gibbon WW, Conaghan PG , et al. The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography[J]. Arthritis Rheum, 2000,43(12):2762-2770.
[5] Wakefield RJ, Balint PV, Szkudlarek M , et al. Musculoskeletal ultrasound including definitions for ultrasonographic pathology[J]. J Rheumatol, 2005,32(12):2485-2487.
[6] Szkudlarek M, Court-Payen M, Strandberg C , et al. Power Doppler ultrasonography for assessment of synovitis in the metacarpophalangeal joints of patients with rheumatoid arthritis: a comparison with dynamic magnetic resonance imaging[J]. Arthritis Rheum, 2001,44(9):2018-2023.
[7] Ball EM, Bell AL . Lupus arthritis—do we have a clinically useful classification?[J]. Rheumatology (Oxford), 2012,51(5):771-779.
[8] Zayat AS, Md Yusof MY, Wakefield RJ , et al. The role of ultrasound in assessing musculoskeletal symptoms of systemic lupus erythematosus: a systematic literature review[J]. Rheumatology (Oxford), 2016,55(3):485-494.
[9] Gabba A, Piga M, Vacca A , et al. Joint and tendon involvement in systemic lupus erythematosus: an ultrasound study of hands and wrists in 108 patients[J]. Rheumatology, 2012,51(12):2278-2285.
[10] Delle SA, Riente L, Scirè CA , et al. Ultrasound imaging for the rheumatologist. ⅩⅩⅣ. Sonographic evaluation of wrist and hand joint and tendon involvement in systemic lupus erythematosus[J]. Clin Exp Rheumatol, 2009,27(6):897-901.
[11] Ruano CA, Malheiro R, Oliveira JF , et al. Ultrasound detects subclinical joint inflammation in the hands and wrists of patients with systemic lupus erythematosus without musculoskeletal symptoms[J]. Lupus Sci Med, 2017,4(1):e000184.
[12] Dreyer L, Jacobsen S, Juul L , et al. Ultrasonographic abnormalities and inter-reader reliability in Danish patients with systemic lupus erythematosus—a comparison with clinical examination of wrist and metacarpophalangeal joints[J]. Lupus, 2015,24(7):712-719.
[13] Geng Y, Han JJ, Deng XR , et al. Presence of power Doppler synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: Experience from a Chinese cohort[J]. Clin Rheumatol, 2014,33(8):1061-1066.
[14] Lins CF, Santiago MB . Ultrasound evaluation of joints in systemic lupus erythematosus: a systematic review[J]. Eur Radiol, 2015,25(9):2688-2692.
[15] Ball EM, Gibson DS, Bell AL , et al. Plasma IL-6 levels correlate with clinical and ultrasound measures of arthritis in patients with systemic lupus erythematosus[J]. Lupus, 2014,23(1):46-56.
[1] Xiaofei TANG, Qiuling DING, Yang ZHANG, Yumei WANG, Meiyi TIAN, Zhuo SUN, Rongrong WANG, Yan CHEN, Jian LIU. Refractory systemic lupus erythematosus-associated thrombocytopenia treated with avatrombopag: A case report [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 405-409.
[2] Xinyi LI, Jinxia ZHAO, Rong MU. Impact of aspirin use on pregnancy outcomes in patients with systemic lupus erythematosus [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1074-1080.
[3] Xiaolin WANG, Shaoyi GUO, Dazhao CHEN, Xijie WEN, Yong HUA, Liang ZHANG, Qin ZHANG. A follow-up study on total hip arthroplasty in patients with systemic lupus erythematosus combined with osteonecrosis of femoral head [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1081-1088.
[4] Chun WEI, Yue YANG, Xinju ZHAO, Xu LIU, Yuan JIA. Systemic lupus erythematosus complicated by autoimmune nodopathy: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1174-1179.
[5] Kai ZHAO, Fu'ai LU, Yongfu WANG. Central nervous system infection mimicking neuropsychiatric systemic lupus erythematosus: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1188-1192.
[6] Wenqiong WANG, Yuke HOU, Chun LI, Xuewu ZHANG. Predictors of adverse pregnancy outcomes in patients with systemic lupus erythematosus [J]. Journal of Peking University (Health Sciences), 2025, 57(3): 599-603.
[7] Hongyan WANG, Xinming LI, Kechi FANG, Huaqun ZHU, Rulin JIA, Jing WANG. Analysis of characteristics related to the disease activity of systemic lupus erythematosus and construction of an evaluation model [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 1017-1022.
[8] Dandan CHEN, Yun LI, Qingyi LU, Xiaohong XIANG, Feng SUN, Yingni LI, Jing ZHAO, Hongyan WANG, Chun LI. Ovarian function in patients of childbearing age with systemic lupus erythematosus [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 1023-1028.
[9] Li WANG, Chao GAO, Huanhuan REN, Yanping SHEN, Xiaowei HUANG, Hong YAO, Dandan HAN. Current status and influential factors of self-management ability in patients with systemic lupus erythematosus [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 1029-1035.
[10] Jing CHAI, Yue WANG, Rong MU, Jinxia ZHAO. Systemic lupus erythematosus involving the fornix column leading to hyponatremia: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 1115-1118.
[11] Mingxia WANG, Ling DING, Min WANG, Chanjuan ZOU, Siyu YAN, Yingwen LIANG, Weijia WANG, Shanzhi HE. Safe pregnancy and delivery in a female patient with systemic lupus erythematosus after discontinuation of dual-target chimeric antigen receptor T cells therapy [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 1119-1125.
[12] Zhihui WU, Mingzhi HU, Qiaoying ZHAO, Fengfeng LV, Jingying ZHANG, Wei ZHANG, Yongfu WANG, Xiaolin SUN, Hui WANG. Immunomodulatory mechanism of umbilical cord mesenchymal stem cells modified by miR-125b-5p in systemic lupus erythematosus [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 860-867.
[13] Limin REN,Chuchu ZHAO,Yi ZHAO,Huiqiong ZHOU,Liyun ZHANG,Youlian WANG,Lingxun SHEN,Wenqiang FAN,Yang LI,Xiaomei LI,Jibo WANG,Yongjing CHENG,Jiajing PENG,Xiaozhen ZHAO,Miao SHAO,Ru Li. Low disease activity and remission status of systemic lupus erythematosus in a real-world study [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 273-278.
[14] Xiang-ge ZHAO,Jia-qing LIU,Hui-na HUANG,Zhi-min LU,Zi-ran BAI,Xia LI,Jing-jing QI. Interferon-α mediating the functional damage of CD56dimCD57+natural killer cells in peripheral blood of systemic lupus erythematosuss [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 975-981.
[15] Hai-hong YAO,Fan YANG,Su-mei TANG,Xia ZHANG,Jing HE,Yuan JIA. Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 966-974.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!